7 completed. 7 Phase 4.
| Phase | Trials | Status |
|---|---|---|
| Phase 4 | 7 | Completed 7 |
Follow Vascular Calcification: new trials by email Literature Review of Vascular Calcification trials Research Report on Vascular Calcification
Tick up to 5 trials to compare them side by side (eligibility, arms, endpoints, adverse events) in a Literature Matrix.
| Trial | Phase | Status | Sponsor | Enrollment | Start | Updated |
|---|---|---|---|---|---|---|
| Vitamin k1 and Its Relation to Vascular Calcification in Hemodialysis Patients oral vitamin k1 (phylloquinone) - Vascular Calcification | Phase 4 | Completed | Assiut University | 120 | 2018-01-01 | 2021-10-05 |
| Vitamin K2 Supplementation and Vascular Calcification Vitamin K 2 - Renal Disease | Phase 4 | Completed | Catholic University of Salta | 59 | 2016-12-01 | 2020-09-09 |
| Risk Factors for Vascular Calcifications in Hemodialysis Patients: to What Extent is Vitamin K2 Deficiency Involved? Menaquinone - Vascular Calcifications | Phase 4 | Completed | Saint-Joseph University | 50 | 2016-08-01 | 2016-09-20 |
| Effect on Vascular Calcification of Replacing Warfarin by Rivaroxaban With or Without VitK2 in Hemodialysis Patients rivaroxaban, Vitamin K2 - Vascular Calcification | Phase 4 | Completed | Onze Lieve Vrouw Hospital | 117 | 2015-11-01 | 2019-01-28 |
| Cinacalcet Versus Parathyroidectomy in Peritoneal Dialysis Patients Cinacalcet, Surgical total parathyroidectomy with forearm autografting - Kidney Failure, Secondary Hyperparathyroidism | Phase 4 | Completed | The University of Hong Kong | 67 | 2010-05-10 | 2021-10-12 |
| Study of the Effect of Alendronate on Vascular Calcification and Arterial Stiffness in Chronic Kidney Disease Alendronate, Placebo - Vascular Calcification, Arteriosclerosis | Phase 4 | Completed | Monash University | 50 | 2007-01-01 | 2010-02-09 |
| ADVANCE: Study to Evaluate Cinacalcet Plus Low Dose Vitamin D on Vascular Calcification in Subjects With Chronic Kidney Disease Receiving Hemodialysis cinacalcet - Chronic Kidney Disease, End Stage Renal Disease | Phase 4 | Completed | Amgen | 360 | 2006-09-01 | 2014-07-23 |
Hyperparathyroidism, Secondary (2) · Kidney Diseases (2) · Renal Insufficiency, Chronic (2) · Arteriosclerosis (1) · Calcinosis (1) · Cardiovascular Diseases (1) · Hyperparathyroidism (1) · Kidney Failure, Chronic (1) · Renal Insufficiency (1) · Vascular Diseases (1)
Calcium Metabolism Disorders (7) · Metabolic Diseases (7) · Nutritional and Metabolic Diseases (7) · Calcinosis (6) · Female Urogenital Diseases (3) · Female Urogenital Diseases and Pregnancy Complications (3) · Male Urogenital Diseases (3) · Urogenital Diseases (3) · Urologic Diseases (3) · Cardiovascular Diseases (2) · Chronic Disease (2) · Disease Attributes (2) · Endocrine System Diseases (2) · Parathyroid Diseases (2) · Pathologic Processes (2)
Vitamin K 2 (3) · Cinacalcet (2) · Alendronate (1) · Rivaroxaban (1) · Vitamin D (1) · Vitamin K 1 (1)
Amgen (1) · Assiut University (1) · Catholic University of Salta (1) · Monash University (1) · Onze Lieve Vrouw Hospital (1) · Saint-Joseph University (1) · The University of Hong Kong (1)
Australia (1) · Belgium (1) · Egypt (1) · Hong Kong (1) · Lebanon (1)
Angela YM Wang, MD, PhD (1) · Mabel Aoun, MD (1) · Peter G Kerr, MBBS FRACP (1)
PMID 10089993, PMID 10584989, PMID 10816185, PMID 12937218, PMID 15284307, PMID 15810001, PMID 17130273, PMID 18046319, PMID 18094365, PMID 18838561, PMID 19082528, PMID 20133489, PMID 20649879, PMID 21233416, PMID 21781006, PMID 22169620, PMID 22267443, PMID 22289649, PMID 22516722, PMID 22648294, PMID 24072176, PMID 24285428, PMID 24326161, PMID 24400802, PMID 24429407, PMID 24685669, PMID 24944752, PMID 25744701, PMID 25804678, PMID 26295257, PMID 26985380, PMID 28592319, PMID 29531291, PMID 34231877, PMID 36869794, PMID 38040277, PMID 38189593, PMID 9194765